Valuation: Cosmos Health Inc.

Market Cap 12.88M 11.26M 10.35M 9.65M 18.3M 1.23B 18.58M 124M 48.31M 603M 48.36M 47.32M 2.08B P/E 2026 *
23.7x
P/E 2027 * 3.39x
Enterprise Value 12.88M 11.26M 10.35M 9.65M 18.3M 1.23B 18.58M 124M 48.31M 603M 48.36M 47.32M 2.08B EV / Sales 2026 *
0.15x
EV / Sales 2027 * 0.12x
Free-Float
65.92%
Yield 2026 *
-
Yield 2027 * -
1 day+17.61%
1 week+37.69%
Current month+28.37%
1 month-12.48%
3 months-22.72%
6 months-53.96%
Current year-52.39%
1 week 0.16
Extreme 0.1616
0.25
1 month 0.16
Extreme 0.1616
0.28
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
1.32
3 years 0.16
Extreme 0.1616
3.42
5 years 0.16
Extreme 0.1616
150
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 2016-02-25
Director of Finance/CFO 44 2020-11-10
Chief Operating Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 59 2014-01-12
Chairman 60 2016-02-25
Director/Board Member 60 2016-11-17
Date Insider Type Main position Quantity % Market Cap.
06-15Buy

Chief Financial Officer

168,135 0.2708%
06-10Buy

Chief Executive Officer

218,447 0.3519%
06-09Buy

Chief Executive Officer

701,447 1.1299%
Change 5-day change 1-year change 3-year change Capi.($)
+17.61%+37.69%-44.08%-92.40% 12.88M
+2.37%+2.98%+9.31%+86.86% 92.06B
+0.51%+0.43%+44.87%+152.61% 55.96B
+2.20%+0.72%-7.31%+236.14% 22.26B
+1.26%+5.43%-10.09%-24.81% 8B
+1.90%+13.78%-26.29%-30.76% 7.76B
+1.89%+6.02%-9.61%-30.25% 6.66B
-2.66%+2.67%+21.60%+33.33% 6.35B
+0.17%+0.88%-2.65%+21.18% 5.36B
+1.86%+6.93%-5.00%-8.21% 3.63B
Average +2.71%+5.27%-2.92%+34.37% 20.81B
Weighted average by Cap. +1.56%+2.45%+14.23%+103.08%

Financials

2026 *2027 *
Net sales 87.3M 76.32M 70.14M 65.37M 124M 8.31B 126M 842M 327M 4.09B 328M 321M 14.08B 111M 96.86M 89.02M 82.97M 157M 10.55B 160M 1.07B 415M 5.19B 416M 407M 17.87B
Net income - -
Net Debt - -
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
26-07-02 US$0.2371 +17.61% 18,865,848
26-07-01 US$0.2016 +9.15% 11,676,430
26-06-30 US$0.1847 +5.54% 40,581,107
26-06-29 US$0.1750 +1.63% 2,714,821
26-06-26 US$0.1722 -7.07% 15,275,890

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. COSM Stock